TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biocell AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
38,296 |
| Financial expenses |
1
|
2,005
|
2 |
| Earnings before taxes |
106
|
1,193
|
10,511 |
| EBITDA |
-716
|
-663
|
4,991 |
| Total assets |
14,373
|
15,569
|
16,221 |
| Current assets |
8,099
|
10,831
|
11,529 |
| Current liabilities |
1,936
|
2,964
|
4,398 |
| Equity capital |
12,437
|
12,605
|
11,823 |
| - share capital |
1,000
|
1,000
|
1,000 |
| Employees (average) |
0
|
0
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
86.5%
|
81.0%
|
72.9% |
| Turnover per employee | 38,296 | ||
| Profit as a percentage of turnover | 27.4% | ||
| Return on assets (ROA) |
0.7%
|
20.5%
|
64.8% |
| Current ratio |
418.3%
|
365.4%
|
262.1% |
| Return on equity (ROE) |
0.9%
|
9.5%
|
88.9% |
| Change turnover |
0
|
-38,296
|
2,458 |
| Change turnover % |
-100%
|
7% | |
| Chg. No. of employees |
0
|
-1
|
1 |
| Chg. No. of employees % | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.